Clinical Trial to Evaluate the Safety of a Study Drug and the Way It Works in the Body with the Possibility of Improved Cognitive Capacities in People with Down Syndrome - Dr. Brian Skotko and his research team from the MassGeneral Hospital Down Syndrome Program are starting another study drug trial. In this clinical trial, an investigational medicine, not yet approved for sale by the FDA, will be studied in people with Down syndrome who meet eligibility criteria. This study drug is hoped to improve the cognitive capacities in some people with Down syndrome. There are a limited number of spots for this clinical trial, and eligible patients are screened in the order in which they contact the research team. This study is being funded by Elan, the developer of the drug in the upcoming study. The upcoming clinical trial will evaluate the safety of the study drug and how it works in the body. The study will take place over 10 weeks and will include 5 clinic visits. To see if your family member is eligible to take part in the study, please review the questions here: buff.ly/1ae0nMH If you would like your family member to participate in this study, or if you have further questions, please contact Mary Ellen McDonough, RN, Senior Clinical research Coordinator in the MassGeneral Hospital Down Syndrome program at, 617-643-5571 or [email protected] Note: The Massachusetts Down Syndrome Congress (MDSC) is informing you of this research on behalf of MassGeneral Hospital Down Syndrome Program. The MDSC is dedicated to ensuring that all members have information about and access to the latest research opportunities; we review each research proposal for content, ethics, and feasibility before forwarding information to you. At no time does the MDSC sell or share your MDSC member contact information with researchers. The MDSC will not be informed by the researchers about who agrees to participate in this research. Your agreement to participate or not to participate will in no way impact any services, support, or resources that you receive from the MDSC. To read about this and other Research Opportunities, go here: buff.ly/1icrI2W
Posted on: Wed, 23 Oct 2013 01:03:13 +0000
Trending Topics
Recently Viewed Topics
© 2015